API tools faq
paste
Steroidsupply

Inhibitor Pharma Raw Powder Apremilast / Otezla For Health

Steroidsupply
Mar 2nd, 2018
45
0
Never
Add comment
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 2.95 KB | None | 0 0
raw download clone embed print report
  1. Inhibitor Pharma Raw Powder Apremilast / Otezla For Health CAS: 608141-41-9
  2.  
  3. Just try a small order to start our cooperation, we will NOT make you down !
  4. Any products interested pls let me know I will give info.in details.
  5. [email protected]
  6. Skype:live:kathelin_4
  7. WhataApp:+8618872220706
  8.  
  9. Product Name: Apremilast (CC-10004)
  10. Synonyms: ApreMilast;(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide;ApreMilast,CC-10004;AcetaMide, N-[2-[(1S)-1-(3-ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-;Appleton West;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide Apremilast (CC-10004;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)
  11. CAS: 608141-41-9
  12. MF: C22H24N2O7S
  13.  
  14. Apremilast Description
  15.  
  16. Apremilast (Otezla) was approved by the FDA on March 21, 2014 for the treatment of adult patients with active psoriatic arthritis. Apremilast is a member of a new class of oral small molecule inhibitors of the phosphosphodiesterase 4 (PDE4) enzyme. When PDE4 is inhibited in immune cells, it results in elevation of intracellular cyclic adenosine monophosphate (cAMP) levels, which can regulate inflammatory mediators. The current clinical data indicate that apremilast is an effective and well tolerated option for the management of psoriasis and PsA in adults.
  17.  
  18. Apremilast Uses
  19.  
  20. Treating active psoriatic arthritis. It is also used to treat moderate to severe plaque psoriasis in certain patients.
  21.  
  22. Apremilast Metabolism and Drug interaction
  23.  
  24. Oral administration of apremilast has an absolute biovailability of 73% with peak concentration at 2.5 hours (Tmax). The half-life of apremilast is 6-9 hours. Apremilast is metabolized by the both cytochrome (CYP) and non-CYP pathways. In vitro studies have demonstrated that apremilast metabolism is primarily mediated by the CYP3A4 pathway. Thus, concomitant use of apremilast with CYP450 enzyme inducers (such as rifampin, phenobarbital, carbamazepine, phenytoin) is not recommended. There are no significant drug-drug interactions with oral contraceptives, ketoconazole, or methotrexate.
  25.  
  26. Apremilast safety information
  27.  
  28. 1. Apremilast may cause depression. The risk may be greater in patients who have a history of depression or suicidal thoughts or actions. Families and caregivers must closely watch patients who take apremilast. It is important to keep in close contact with the patient's doctor. Tell the doctor right away if the patient has new, worsened, or sudden symptoms, such as depression; anxiety, restlessness, or irritability; panic attacks; or any changes in behavior. Contact the doctor right away if any signs of suicidal thoughts or actions occur.
  29. 2. Apremilast may cause weight loss. You will need to have regular weight checks while you are taking apremilast.
Add Comment
Please, Sign In to add comment
Public Pastes
We use cookies for various purposes including analytics. By continuing to use Pastebin, you agree to our use of cookies as described in the Cookies Policy.  OK, I Understand
Not a member of Pastebin yet?
Sign Up, it unlocks many cool features!